This poster explores an innovative technology that simplifies the construction of bispecific antibodies, enabling rapid and ...

Modex’s antibodies contain multiple binding sites and can target several parts of SARS-CoV-2’s spike protein, the tool the ...

About CRB-701 CRB-701 (SYS6002) is a next-generation antibody-drug-conjugate (ADC) targeting Nectin-4, that contains a site-specific, cleavable linker and a homogenous drug antibody ratio of 2, using ...

The Madras High Court set aside the rejection of Kymab Limited's patent application, ruling that the invention for antibody ...

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to I TM ), today announced a strategic collaboration with OverT Bio, a New York -based biotechnology ...

High DAR Dual-Payload ADC Sutro unveils unique cell-free capabilities Proprietary cell-free platform enables the design of ...

Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of up to $205 million if all options are executed Development ...

Mpox – formerly known as monkeypox – is rapidly spreading in several African countries, prompting the World Health ...

As companies roll out data showing the power and improved safety profile of antibodies that target two antigens, analysts say ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...